COMMUNICATION
Acknowledgements
Financial support of this work by the
Deutsche Forschungsgemeinschaft is
gratefully acknowledged. We thank
Prof. Dr. M. M. Rafi, Rutgers Univer-
sity, New Brunswick, USA, for
a
sample of natural 1,6-O,O-diacetylbri-
tannilactone (1c).
Keywords: antitumor agents ·
natural products
·
structure
elucidation · terpenoids · total
synthesis
[1] For the isolation of 1a–1c, see:
a) B.-N. Zhou, N.-S. Bai, L.-Z.
Ling, G. A. Cordell, Phytochemis-
try 1993, 34, 249–252; b) F. Jeske,
S. Huneck, J. Jakupovic, Phyto-
Scheme 2. Synthesis of triol 11 from carboxylic acid 2. a) i) IACHTNUGTRNE(UNG col)2PF6, toluene, 08C, ii) Bu3SnH, AIBN, tolu-
ene, 758C, 73% 4/5 (4.8:1); b) LiBH4, THF, 08C!RT, 82% (2 steps); c) TrCl, DMAP, pyridine, CH2Cl2, RT,
100%; d) Dess–Martin periodinane, pyridine, CH2Cl2, RT, 98%; e) Bu4NF, AcOH, THF, RT, 100%; f) Red-
Al, CH2Cl2, toluene, ꢀ208C!RT, 83 %; g) i) Bu4NF, MS (4 ꢂ), THF, 858C (sealed tube) ii) KF, H2O2,
NaHCO3, THF, MeOH, 858C (sealed tube), 91%. Tr=triphenylmethyl, col=sym-collidine, AIBN=azobisiso-
butyronitrile, DMAP=4-(N,N-dimethylamino)pyridine, Red-Al=sodium bis(2-methoxyethoxy)aluminum hy-
dride, MS=molecular sieves.
[2] For the relative configuration of 1
illustrated in Scheme 1, see
Ref. [1b], as well as the depicted
crystal structures of 1b in: a) A.-
R. Han, W. Mar, E.-K. Seo, Nat.
Prod. Sci. 2003, 9, 28–30; b) S.
Liu, H. Liu, W. Yan, L. Zhang, N.
[3] a) C. Yang, C.-M. Wang, Z.-J. Jia,
Planta Med. 2003, 69, 662–666;
b) C.-T. Ho, M. Rafi, R. S. Dipao-
la, G. Ghai, R. T. Rosen, N. Bai,
US 6627623 B2, 2003; c) M. M.
Rafi, N.-S. Bai, C.-T. Ho, R. T.
Rosen, E. White, D. Perez, R. S.
Dipaola, Anticancer Res. 2005, 25,
313–318; d) S. Liu, H. Liu, W.
Yan, L. Zhang, N. Bai, C.-T. Ho,
K. He, Z. Zhou, L. Zhang, Z.
Quan, N. Zhu, Q. Y. Zheng, M.-
Wang, Z.-J. Jia, R.-L. Zheng,
Scheme 3. Completion of the synthesis of 1a and 1c. a) TEMPO (50 mol%), NCS, Bu4NCl (10 mol%),
CH2Cl2, H2O, pH 8.6, RT, 77%; b) TMSCl, imidazole, CH2Cl2, 08C, 100%; c) NaH, paraformaldehyde, DMF,
RT; d) Bu4NF, THF, 08C, 35% (2 steps); e) TsOH, MeOH, RT, 100%; f) Ac2O, pyridine, RT, 67%. TEMPO=
2,2,6,6-tetramethylpiperidine-1-oxyl (free radical), NCS=N-chlorosuccinimide, TMSCl=Trimethylsilyl chlo-
ride , TsOH=toluenesulfonic acid.
tical rotation data.[18] To determine without any doubt if the
relative configuration of (+)-britannilactone depicted in the
literature[1a] should be revised to that of 1a, we repeated the
published procedure for isolation[1a] of this sesquiterpene
lactone from Inula britannica flowers.[19] As anticipated, the
X-ray diffraction analysis of natural 1a obtained in this way
unambiguously verified the 6a orientation of the secondary
hydroxyl group.[11] Finally, conversion of synthetic 1a to the
diacetate also gave (ꢀ)-1c, which, by comparison of the
spectral and optical rotation data, was also found to be iden-
tical to the natural product.[20]
[4] Recently, a non-natural acyl derivative of 1b (ABL-N) was shown
to induce apoptosis in breast cancer cells and cause significant inhib-
ition of tumor growth in vivo: B. Liu, M. Han, J.-J. Wang, Y.-P.
[5] a) K.-H. Je, A.-R. Han, H.-T. Lee, W. Mar, E.-K. Seo, Arch. Pharm.
Han, J.-K. Wen, J. Pharmacol. Exp. Ther. 2008, 324, 292–298; e) Y.-
P. Liu, J.-K. Wen, Y.-B. Wu, J. Zhang, B. Zheng, D.-Q. Zhang, M.
Hennig, P. Schwab, R. Frçhlich, S. V. Tokalov, H. O. Gutzeit, P.
In conclusion, a short enantioselective route to britanni-
lactone (1a) and 1,6-O,O-diacetylbritannilactone (1c) has
been developed that also confirmed the relative and abso-
lute configuration of these bioactive natural products.
Chem. Eur. J. 2011, 17, 3332 – 3334
ꢁ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3333